Identification of Shared Genes and Mechanisms Linking Vascular Smooth Muscle Cell Osteogenic Transdifferentiation and Atherosclerosis

Feng Wang,Qionghui Huang,Qimin Wu,Lishu Wang,Huanji Zhang
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20233711.559
2023-01-01
Journal of biological regulators and homeostatic agents
Abstract:Background: Atherosclerosis is a complex and pervasive chronic disease with a substantial global health impact. Emerging evidence highlights the role of osteogenic transdifferentiation in vascular smooth muscle cells (VSMCs) as a contributor to atherosclerosis development. However, the precise molecular mechanisms involved remain unclear. This study aimed to uncover common genes that link osteogenic transdifferentiation of VSMCs and atherosclerosis. Methods: We conducted weighted gene co-expression network analysis (WGCNA) using publicly available atherosclerosis-related datasets, namely GSE43292 and GSE28829. We identified key module genes that exhibited a positive correlation with both osteogenic transdifferentiation and atherosclerosis, designating them as Geneset 1. Functional enrichment analysis of Geneset 1 was conducted using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. We further screened for upregulated differentially expressed genes in the GSE135626 dataset that intersected with Geneset 1, resulting in the identification of genes with positive associations with osteogenic transdifferentiation of VSMCs and atherosclerosis, designat-ing them as Geneset 2. We validated the expression of Geneset 2 in the osteogenic-induced VSMCs cell line (MOVAS-1) through RT-qPCR and identified hub genes. The hub genes were further validated in mouse atherosclerotic plaque samples using immunohistochemistry (IHC). Moreover, we performed receiver operating characteristic (ROC) analysis to assess the predictive value of the hub genes for atherosclerotic plaque progression and stability. Furthermore, we constructed a network illustrating the interaction between transcription factors (TFs) and hub genes based on our findings.Results: Using WGCNA, we identified three significant gene modules and 99 osteogenic-related genes positively associated with atherosclerosis in Geneset 1. These genes were primarily involved in osteoclast differentiation pathways, exosome secretion-related functions, and immunoinflammatory processes according to GO and KEGG analysis. Subsequently, we isolated 11 candidate genes (Geneset 2) that demonstrated a positive linkage between osteogenic transdifferentiation of VSMCs and atheroscle-rosis. RT-qPCR confirmed the upregulation of four hub genes (branched-chain amino acid transaminase 1 (BCAT1), receptor-interacting protein kinase 3 (RIPK3), haematopoietic cell kinase (HCK), and plasminogen activator urokinase receptor (PLAUR)) from Geneset 2 in osteogenic-induced MOVAS-1 cells and in mouse atherosclerotic plaque samples through IHC. Moreover, the four hub genes exhibited strong predictive values for atherosclerotic plaque progression and stability in ROC analysis. Finally, we identified 26 TFs that target the hub genes, shedding light on potential regulatory mechanisms.Conclusions: This study identifies BCAT1, RIPK3, HCK, and PLAUR as shared hub genes linking osteogenic transdifferentiation of VSMCs and atherosclerosis. These findings provide valuable insights for future research.
What problem does this paper attempt to address?